AnalystsInsight

Deane Dray (RBC Capital): Analyst Track Record and Price‑Target Accuracy

How often Deane Dray’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 3,105 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Deane Dray ranks #590 of 1,000 analysts in Exent’s scoring (4.8★).
  • 62.8% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 84 days; 74.1% of calls were up 12 months later.
  • Most‑covered stocks: NVT, LII, VRT, GGG.
  • Free on Exent: Deane Dray’s full record, with ratings 3 days after publication.

Deane Dray’s track record at a glance

Deane Dray of RBC Capital ranks #590 of the 1,000 analysts Exent scores, with a 4.8★ rating and a focus on industrials. Over a 7‑year lookback, 62.8% of Deane’s price targets were reached, 10.4 points above the 52.4% average across all analysts.

MetricDeane DrayAll analysts
Price‑target hit rate62.8%52.4%
Median days to hit target84 days91 days
Calls up after 12 months74.1%64.0%
Median 12‑month return of calls+16.8%+13.4%
Hit rate, last 2 years63.7%—
Average worst drop after a call−14.6%—
Ratings in the sample3,105—
Stocks covered32—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetDeane Dray
Under 30 days28.3%
30–90 days24.7%
90–180 days22.6%
Over 180 days24.4%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Deane Dray covers most

StockRatings in the sample
NVT26
LII24
VRT22
GGG22
HON18
CARR18
IEX17
PNR17

In the past year Deane’s ratings were 58% Buy, 39% Hold and 3% Sell.

Deane Dray’s latest ratings

DateStockActionRatingPrice target
Sep 11, 2026VLTOMaintained: HoldHold$109.00
Aug 18, 2026HONReiterated: BuyBuy$293.00
Aug 17, 2026ROPReiterated: HoldHold$417.00
Aug 4, 2026EMRReiterated: BuyBuy$179.00
Aug 4, 2026AMERated: BuyBuy$291.00
Aug 4, 2026GWWReiterated: HoldHold$1428.00
Aug 3, 2026ATKRReiterated: HoldHold$95.00
Aug 2, 2026GTESReiterated: BuyBuy$34.00
Aug 2, 2026NVTReiterated: BuyBuy$200.00
Aug 2, 2026ETNReiterated: BuyBuy$512.00
Jul 31, 2026TTReiterated: HoldHold$496.00
Jul 31, 2026WCCReiterated: BuyBuy$430.00
  • Sep 11, 2026
    Stock
    VLTO
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $109.00
  • Aug 18, 2026
    Stock
    HON
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $293.00
  • Aug 17, 2026
    Stock
    ROP
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $417.00
  • Aug 4, 2026
    Stock
    EMR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $179.00
  • Aug 4, 2026
    Stock
    AME
    Action
    Rated: Buy
    Rating
    Buy
    Price target
    $291.00
  • Aug 4, 2026
    Stock
    GWW
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $1428.00
  • Aug 3, 2026
    Stock
    ATKR
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $95.00
  • Aug 2, 2026
    Stock
    GTES
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $34.00
  • Aug 2, 2026
    Stock
    NVT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $200.00
  • Aug 2, 2026
    Stock
    ETN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $512.00
  • Jul 31, 2026
    Stock
    TT
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $496.00
  • Jul 31, 2026
    Stock
    WCC
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $430.00

Deane’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Deane Dray’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Deane Dray ranks #590 of 1,000 with a 4.8★ rating. 62.8% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 74.1% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Deane Dray’s success rate is 59.1% by the ranking source and 62.8% by Exent’s price-target hit-rate backtest, with a median of 84 days to reach a target.

Deane Dray (RBC Capital) covers 32 stocks, mostly in industrials. The most frequently rated are NVT, LII, VRT, GGG, HON.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.